ISRCTN41082378
Completed
Not Applicable
ew therapeutic approach to Tourette Syndrome in children based on a randomised placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6
The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)0 sites38 target enrollmentSeptember 30, 2008
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)
- Enrollment
- 38
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 7 \- 14 years, either sex. This is the age bracket during which the natural course of the illness is most exacerbated. Before the age of 7 years, the tics may not yet have appeared (this generally occurs at the age of 5 \- 7 years). After 14 years, symptoms tend to stabilise.
- •2\. Informed consent of the child's parents or guardians, and reasoned agreement with the child
- •3\. Clinical diagnosis of TS, according to Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM\-IV) criteria
- •4\. Score of 40 or more on the YGTSS
Exclusion Criteria
- •1\. Severe attention deficit hyperactivity disorder (ADHD) or obsessive compulsive disorder (OCD), not clinically controlled
- •3\. Unrelated depression
- •4\. Allergy to acetylsalicylic acid (due to the excipients used)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Group Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: CBIT vs Psycho-Educational InterventionTourette SyndromeMotor or Vocal Tic Disorder, ChronicNCT02407951Tel-Aviv Sourasky Medical Center96
Completed
Not Applicable
Behavioral Therapy for Children and Adolescents With Tourette SyndromeTourette SyndromeNCT03621059Taipei Medical University46
Completed
Phase 2
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 YearsTourette's SyndromeNCT02102698Emalex Biosciences Inc.40
Completed
Phase 1
Ecopipam Treatment of Tourette SyndromeTourette's SyndromeNCT01244633Psyadon Pharma18
Withdrawn
Not Applicable
eural Structure and Function in Tourette Syndrome: distinguishing neural structure and function in Tourette Syndrome from attention-deficit/hyperactivity disorder.ontwikkelingsstoornissen NEGTourette's and ADHDNL-OMON41025Donders Institute of Brain, Cognition and Behavior60